BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27187376)

  • 1. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
    Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
    Tsai WC; Hueng DY; Nieh S; Gao HW
    J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
    Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
    Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas.
    Huang ZY; Hueng DY; Tsai WC
    Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):74-82. PubMed ID: 30664534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of pentraxin 3 and nuclear factor-like 2 implying a relatively longer overall survival time in gliomas.
    Ke HH; Hueng DY; Tsai WC
    Chin J Physiol; 2019; 62(1):35-43. PubMed ID: 30942197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
    Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
    J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of Endocan in Patients with Meningiomas and Gliomas.
    Atukeren P; Kunbaz A; Turk O; Kemerdere R; Ulu MO; Turkmen Inanir N; Tanriverdi T
    Dis Markers; 2016; 2016():7157039. PubMed ID: 27528791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
    Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
    Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
    Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
    Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
    J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of hypoxia-inducible factor-1 in primary brain tumors.
    Reszec J; Rutkowski R; Chyczewski L
    Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of nuclear factor erythroid-derived 2-like 2 and p62/sequestosome expression on prognosis of patients with gliomas.
    Zhao M; Xu H; Zhang B; Hong B; Yan W; Zhang J
    Hum Pathol; 2015 Jun; 46(6):843-9. PubMed ID: 25841304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.
    Waage IS; Vreim I; Torp SH
    Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
    Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
    Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ; Shi DL; Huang W; Chen F; Lu YC
    J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression.
    Kleinschmidt-DeMasters BK; Orr EA; Savelieva E; Owens GC; Kruse CA
    J Neurooncol; 1999 Jan; 41(1):31-42. PubMed ID: 10222420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.